Member Info for DonaldTrumpsWig

Tim, it could be semantics and it could also be how the author has recounted in writing what was a verbal exchange with AS.
I do however believe the veracity of the exchange however, for two reasons, firstly, anyone claiming to have suffered from cancer to glean info would be beyond the pale and unlikely and secondly, if confronted with such a question when faced by a former cancer sufferer, I am convinced that AS would fully understand the question however it was worded and his answer would be unequivocal regardless of whether it related to current or future recipients of AVA6k

It was Linkedin not Twit and didn't one of the Directors daughters also start posting indiscreet info too. Glad to see the back of those days

Fantastic, research and theorising over the last couple of weeks, thanks to all contributors

It seems perverse that as we sit on the brink of a potentially seismic shift in cancer treatment the SP sits below placing, yet a year ago the SP jumped double digits % because some numpty from ODX posted on twatter that he was working on AVCTs LFT.

I'm of the firm opinion that the AVCT have no interest in the current SP, they have a clear strategy to window dress the business for a sale. I believe the notional date for this was prior to next summer when the cash was initially due to run out. In light of today's injection and subsequent milestone payments this date could be extended providing the company with additional opportunities to progress developments in-house, thereby adding further value.

AIM is clearly irrelevant to the end game, it's a poorly managed and regulated market populated by under researched rainbow chasers. AVCT will never be taken seriously whilst listed on AIM, only when it is listed on NASDAQ will it's value be appropriately researched and identified.
I believe however that NASDAQ may also be irrelevant, as once 'data rich' conclusions are available, a detailed prospectus will be prepared and appropriate agents will be engaged to market the company to both existing partners and new suitors alike.
The beauty of today's RNS is that it suggests that ongoing revenues are likely to come on stream that will prevent the BOD from being 'lowballed' by a speculative bid, which with cash running out they might be obliged to consider.

I suggest ignoring the short-term SP, it is almost irrelevant unless you are a trader, one day soon we will wake up with the share suspended and an RNS asking us to consider a price offer of £££ which the BOD recommend we accept

Paul Hill says 'multiple shots on goal' 50 times, soils himself with excitement, then explains that he's not invested and the SP tanks, one to avoid I suggest.

Agreed Mr R, if my boots weren't already overflowing I'd be filling them at £1.09 after todays RNS

Mossman
The naivety of your question clearly gives away the fact that you have never owned a single AVCT share let alone held them 'for a good few years'
Give it up

PJT
My comments were not aimed at you personally and I'm sorry if you viewed it that way. They were aimed at the regular 'bashers' who appear daily and use the LFT and the lack of share purchases to unsettle novice investors.

I will however pick you up on some of your research, particularly the bit about me being a 'rookie' and a 'newbie'. I've been invested since 2019 and a quick check will show I've been posting on here since 2020, I might also add that my shaving mirror reminds me every morning that I am almost certainly one of the 'seniors'
Oh and if you don't like offensive language then holding PL, Timster and Rorke's up as paragons of virtue is probably a mistake (I'm sure their **** count is way ahead of mine)
Having said that, like you, I am grateful for the excellent contributions we've received in recent days and as a heavily invested LTH I'm incredibly excited at both the financial and holistic benefits AVCT will bring to us all.

'SP not reflecting what can be inferred from some very informed private investors. I think this is because investor sentiment 'bruised' from LFT fiasco'
That statement is somewhat of an oxymoron, very informed PI's are not bruised from the LFT fiasco because they know the current opportunity has zero reference to the LFT beyond the funds it provided via the raise.
Any PI that doesn't understand that is either a moron or so under researched they really shouldn't be investing their hard earned here.
On the subject of the ongoing pathetic bashing attempts based on the lack of Director share purchases, again, research would tell the morons via the RNS of the 28th April an additional 2,000,000 shares were made available via EMI & LTIP schemes to ADD to 'the outstanding options ALREADY issued'

Nothing we didn't know already, looks like read out has been pushed back a little into Q3 but nothing to suggest anything is going wrong. Reassuring in the sense that funding remains in place until well after P1a is complete

Looks like us LTH's will have to exhibit a little more patience but who knows what discussions are taking place in the interim?

Worth reminding ourselves that the AVCT board have set out their near term objectives in terms of trial status, outcomes sought/expected and timelines.
They are not obliged to give us a running commentary of how the trials are progressing but they DO have a clear fiduciary obligation to RNS any developments that could have a negative impact on the SP.

In this instance I would suggest therefore that no news is indeed good news.

'We need the actual data now (not just clues in language etc) to move further by the looks. mid summer will be here before you know it....'
Then, never mind bench to bedside it could be beach to poolside .....see what I did there ??

Several years ago, I was a director of a company that introduced a EMI scheme for key staff. As Richob has pointed out it requires HMRC sign off as it is a tax efficient way of rewarding key staff.

Read into what you will but the company I worked for introduced the scheme in advance of planned corporate activity (management buy out) to ensure that the recipients were able to take advantage of the sale as tax efficiently as possible.

'This stock is 100% sentiment driven at these levels and volumes.' - Exactly

And for our resident Sealion (need to stop calling him Sealion as they can often be likeable and entertaining) to infer that current SP movements have any relevance to a time when the SP was entirely LFT sentiment driven, marks him out as having an intellect positioned somewhere between ****** and neanderthal

The circumstances that influence a share price at any given time are unique to that particular period in time.
To suggest that those circumstances remain relevant to the current share price, simply because they happened before is beyond idiotic.

Good post Energy

A humbling reminder that this small, virtually unknown company we are invested in, is, as we type, possibly making significant improvements to the life chances of a handful of desperately ill people.

Whilst most of us are here to make money we must never forget that making money is nothing other than an insignificant bi-product of the palpable relief and hope that several families could well be experiencing right now as a result of being part of our first cohort.

Very best wishes to them all and great credit to all LTH's who are helping to fund these trials.

Wyndrum at 12.24

'That's why you often get "buy on the rumour and sell on the news": the price already reflected the expectation of good news and it only needs not to exceed that expectation for money to be taken off the table and chase some other rainbow'

Classic Sealioning of this AVCT board. Always able to defend his/her posts with 'I'm only adding some perspective' or 'nobody is influenced by opinions on a BB' or 'I'm only trying to explain how charting works'.

Under a cloak of innocuous chit chat, such posts are (not very) cleverly designed to apply a granular sprinkling of doubt, encouraging PI's to ask themselves such questions as; 'perhaps all the recent good news has now already been priced in and a retrace is imminent' ? 'Should I sell a few and try to trade the drop'?
If there is anyone stupid enough to succumb to this drip feed of 'harmless opinion' please try very hard to avoid the sea lion.
Golden rule #1 - ignore any poster or topic that is discussing the share price or it's imminent movements.

Golden rule # 2 - Use this board only for the posters that share knowledge relating to the science (some of which is brilliant) and posters who research relevant information such as new appointments and science taking place with partners/competitors.

Tip: Wyn very rarely contributes to any science based discussions which should tell you everything you need to know about his motives.

Note to Wyn, please don't bother with a long boring riposte, I can't be @rsed

I've mentioned before that I firmly believe Dr Smith and the team are window dressing the business for a sale.
The summer results could represent the pinnacle of work that has been ongoing for decades. The management team will own significant share options and why wouldn't they want to set themselves up for life whilst allowing a larger, better resourced company bring their pipeline to market. It's actually common sense and would expedite the benefits to millions of cancer sufferers.
What value the SP at this point ? entirely dependent on the summer results, however, listening to Dr Smith over the last couple of weeks we can only deduce that the direction of travel could genuinely revolutionise the fight against cancer.
And for AVCT and 'cure for cancer' to be mentioned in the same sentence would not see the company valued in the billions it could readily be the 10's of billions.

'Other technologies are easy to copy when you don't have to go through clinical trials to market them globally, with a drug like this even if they did manage to copy it they would not get regulatory approval to sell it anywhere other than China.'

Unless you are selling it to Jim Bythell and The UK's DHSC, they will buy anything from anyone !!

A great week and another important step towards revolutionising outcomes for millions of cancer sufferers

Have a great weekend

This mornings RNS serves as a reminder of how quickly LTHs fortune’s could change if and when one or both of the major divisions are sold off. No warning, no leaks.
Go to bed underwater, wake up to an indicative offer.
Believe in your research and stay patient.